The results of this study demonstrate significant enrichment of NRAP variants in DCM patients with severe clinical events and their co-segregation in multiple families support an inclusion of NRAP in genetic testing of cardiomyopathies. This evidence concerns the gene NRAP and familial dilated cardiomyopathy.